新着情報
- 2025.01.30 ホームページが公開されました。
元モーニング娘。の石黒彩さんとの対談
元モーニング娘。の石黒彩さんとの対談の内容が、2026年1月1日のCOMPANY TANK2026年1月号で発刊となりました。対談の内容は、以下のURLで公表されています。
マスモトハートメディカル 合同会社 代表 増本 直広 | Challenge+ チャレンジプラス
マスモトハートメディカル 合同会社 代表 増本 直広 | Challenge+ チャレンジプラス
Masumoto Heart Medical – CEO Profile & Clinical/Regulatory Capabilities
Masumoto Heart Medical LLC
“Love Saves the Earth, Medicine Saves Lives.”
Clinical & Regulatory Capabilities
Our team consists of specialists with extensive experience in global clinical trials, domestic trials in Japan, post-marketing surveillance (PMS), clinical research, and regulatory submissions/approvals for the following advanced medical devices:
Cardiovascular & Structural Heart
- Coronary Artery Disease: Bioresorbable Vascular Scaffolds (BVS), Drug-Coated Balloons (DCB), Drug-Eluting Stents (DES).
- Valvular Heart Disease: Transcatheter Aortic Valve Implantation (TAVI), Transcatheter Mitral Valve Repair (TMVr), Surgical Aortic Valve Replacement (SAVR).
- Arrhythmia: Dual-Chamber Leadless Pacemakers, Single-Chamber Leadless Pacemakers, Extravascular Implantable Cardioverter-Defibrillators (EV-ICD).
- Heart Failure: Implantable Left Ventricular Assist Devices (LVAD), Cardiac Resynchronization Therapy (CRT).
Specialized Therapeutic Areas
- Peripheral Vascular Disease: Orbital Atherectomy Devices, Endovenous Closure Devices for Varicose Veins.
- Urology: Sacral Neuromodulation Systems for Overactive Bladder.
- Respiratory Disorders: Hypoglossal Nerve Stimulation Devices for Obstructive Sleep Apnea.
👤 Chief Executive Officer
Naohiro Masumoto, Ph.D.
Professional Experience
- Over 20 years of expertise in cardiovascular medical device development.
- Served in key leadership roles (Study Director, Study Manager, Lead Scientist) at global top-tier companies, including:
- Johnson & Johnson
- Abbott Laboratories
- Medtronic
Awards
- Abbott Structural Heart President’s Award (2017)
- MitraClip Japan Shonin Approval (Contribution to the successful regulatory approval in Japan)
Education & Academic Credentials
- Ph.D. in Pharmaceutical Sciences (Major: Cardiovascular Pharmacology), Graduate School of Pharmaceutical Sciences, University of Shizuoka.
- Graduate of Shizuoka Prefectural Hamamatsu Kita High School.
- Licensed Pharmacist (Japan).
Selected Publications (First Author)
Published research in world-renowned pharmacology journals:
Published research in world-renowned pharmacology journals:
- Naohiro Masumoto, et al.: "Specific attenuation of the pressure-induced contraction of rat cerebral artery by herbimycin A." European Journal of Pharmacology, 330: 55–63 (1997).
- Naohiro Masumoto, et al.: "Attenuation of pressure-induced myogenic contraction and tyrosine phosphorylation by fasudil in rat cerebral artery." British Journal of Pharmacology, 130: 219–230 (2000).
- Naohiro Masumoto: "Introduction of the CellSearch Circulating Tumor Cell (CTC) Detection System." Igaku no Ayumi, 228(11): 1079–1083 (2009).
Contact Information
- Tel: +81-70-6568-1001
- Email: mhm20241001@yahoo.ne.jp





